Kenji Idehara

Summary

Affiliation: Daicel Chemical Industries
Country: Japan

Publications

  1. doi request reprint Interlaboratory validation of the modified murine local lymph node assay based on adenosine triphosphate measurement
    Takashi Omori
    Kyoto University School of Public Health, Japan
    J Pharmacol Toxicol Methods 58:11-26. 2008
  2. doi request reprint Characterization and evaluation of a modified local lymph node assay using ATP content as a non-radio isotopic endpoint
    Kenji Idehara
    Analysis Service Center, Daicel Chemical Industries, Ltd, 1239, Shinzaike, Aboshi ku, Himeji, Hyogo 671 1283, Japan
    J Pharmacol Toxicol Methods 58:1-10. 2008
  3. ncbi request reprint An evaluation of performance standards and non-radioactive endpoints for the local lymph node assay. The report and recommendations of ECVAM Workshop 65
    David Basketter
    St John s Institute of Dermatology, St Thomas Hospital, London, UK
    Altern Lab Anim 36:243-57. 2008

Detail Information

Publications3

  1. doi request reprint Interlaboratory validation of the modified murine local lymph node assay based on adenosine triphosphate measurement
    Takashi Omori
    Kyoto University School of Public Health, Japan
    J Pharmacol Toxicol Methods 58:11-26. 2008
    ..Daicel Chemical Industries Ltd. has developed a modified LLNA based on the adenosine triphosphate (ATP) content (LLNA-DA). We conducted 2 interlaboratory validation studies to evaluate the reliability and relevance of LLNA-DA...
  2. doi request reprint Characterization and evaluation of a modified local lymph node assay using ATP content as a non-radio isotopic endpoint
    Kenji Idehara
    Analysis Service Center, Daicel Chemical Industries, Ltd, 1239, Shinzaike, Aboshi ku, Himeji, Hyogo 671 1283, Japan
    J Pharmacol Toxicol Methods 58:1-10. 2008
    ..Here, we describe a non-radio isotopic modified LLNA in which adenosine triphosphate (ATP) content is used as an endpoint instead of radioisotope (RI); the method is termed LLNA modified by Daicel based on ATP content (LLNA-DA)...
  3. ncbi request reprint An evaluation of performance standards and non-radioactive endpoints for the local lymph node assay. The report and recommendations of ECVAM Workshop 65
    David Basketter
    St John s Institute of Dermatology, St Thomas Hospital, London, UK
    Altern Lab Anim 36:243-57. 2008